...
首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >National Emphysema Treatment Trial redux: accentuating the positive.
【24h】

National Emphysema Treatment Trial redux: accentuating the positive.

机译:全国性肺气肿治疗试验redux:强调积极。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Under the Freedom of Information Act, we obtained the follow-up data of the National Emphysema Treatment Trial (NETT) to determine the long-term outcome for "a heterogeneous distribution of emphysema with upper lobe predominance," postulated by the NETT hypothesis to be optimal candidates for lung volume reduction surgery. METHODS: Using the NETT database, we identified patients with heterogeneous distribution of emphysema with upper lobe predominance and analyzed for the first time follow-up data for those receiving lung volume reduction surgery and those receiving medical management. Furthermore, we compared the results of the NETT reduction surgery group with a previously reported consecutive case series of 250 patients undergoing bilateral lung volume reduction surgery using similar selection criteria. RESULTS: Of the 1218 patients enrolled, 511 (42%) conformed to the NETT hypothesis selection criteria and received the randomly assigned surgical or medical treatment (surgical = 261; medical = 250). Lung volume reduction surgery resulted in a 5-year survival benefit (70% vs 60%; P = .02). Results at 3 years compared with baseline data favored surgical reduction in terms of residual volume reduction (25% vs 2%; P < .001), University of California San Diego dyspnea score (16 vs 0 points; P < .001), and improved St George Respiratory Questionnaire quality of life score (12 points vs 0 points; P < .001). For the 513 patients with a homogeneous pattern of emphysema randomized to surgical or medical treatment, lung volume reduction surgery produced no survival advantage and very limited functional benefit. CONCLUSIONS: Patients most likely to benefit from lung volume reduction surgery have heterogeneously distributed emphysema involving the upper lung zones predominantly. Such patients in the NETT trial had results nearly identical to those previously reported in a nonrandomized series of similar patients undergoing lung volume reduction surgery.
机译:目的:根据《信息自由法》,我们获得了国家肺气肿治疗试验(NETT)的后续数据,以确定NETT假设所假设的“具有上叶优势的肺气肿的异质分布”的长期结果是减少肺体积的最佳选择。方法:使用NETT数据库,我们发现肺气肿分布不均且以上叶为主的患者,并首次分析了接受肺减容手术和药物治疗的患者的随访数据。此外,我们将NETT减少手术组的结果与先前报道的连续250例使用相似选择标准进行双侧肺减容手术的患者进行了比较。结果:在1218名患者中,有511名(42%)符合NETT假设选择标准,并接受了随机分配的手术或药物治疗(手术= 261;药物= 250)。肺减容术可带来5年生存获益(70%比60%; P = .02)。与基线数据相比,在3年时的结果有利于减少残余体积(25%vs 2%; P <.001),加利福尼亚大学圣地亚哥分校呼吸困难评分(16 vs 0分; P <.001)和减少手术量。改善了圣乔治呼吸问卷的生活质量得分(12分vs 0分; P <.001)。对于513例肺气肿均一的模式,随机分配给外科或药物治疗的患者,肺减容术无生存优势,功能获益非常有限。结论:最可能受益于肺减容术的患者的肺气肿分布不均,主要累及上肺区。 NETT试验中的此类患者的结果与先前在进行肺减容手术的一系列非随机性类似患者中报道的结果几乎相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号